Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Myslowice – page 4

45 clinical trials in Myslowice, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Myslowice at a glance
45
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

45 trials in Myslowice

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:AB-729
  • Sponsor:Arbutus Biopharma Inc.

Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Seladelpar
  • Sponsor:Gilead Sciences Inc.

Study of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Safety and Tolerability of A3907 for Adults with Primary Sclerosing Cholangitis (PSC)

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:A3907
  • Sponsor:Albireo AB

Urea cycle disorder+3

Not recruiting

Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Hhalpc
  • Sponsor:Cellaïon SA

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rifaximin
  • Sponsor:Salix Pharmaceuticals Inc.

Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Linerixibat
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Norucholic Acid
  • Sponsor:Dr. Falk Pharma GmbH

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Myslowice

What the registry says about research in the country

01 Liver Disease Studies

Groundbreaking research focusing on Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis, evaluating novel therapeutic approaches and treatments. Studies are examining the safety and efficacy of experimental medications for these chronic liver conditions.

  • Cholangitis treatments
  • Liver fibrosis management
  • Chronic liver disease therapy
02 Cancer Research

Advanced clinical trials investigating treatments for Hepatocellular Carcinoma and Non-Muscle Invasive Bladder Cancer. Studies are evaluating combination therapies and immunotherapy approaches to improve patient outcomes.

  • Liver cancer treatments
  • Bladder cancer therapies
  • Immunotherapy studies
03 Metabolic Disorders

Innovative research on Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis (NASH). Studies are exploring new combination therapies and investigating treatments for liver complications associated with metabolic conditions.

  • Diabetes management
  • NASH treatments
  • Metabolic disease therapy
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.